St. Jude Medical VP Kathy Chester Sells 20,000 Shares (STJ)
St. Jude Medical (NYSE:STJ) VP Kathy Chester sold 20,000 shares of St. Jude Medical stock on the open market in a transaction that occurred on Wednesday, October 23rd. The stock was sold at an average price of $56.50, for a total value of $1,130,000.00. Following the transaction, the vice president now directly owns 4,830 shares of the company’s stock, valued at approximately $272,895. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at RBC Capital raised their price target on shares of St. Jude Medical from $40.00 to $44.00 in a research note to investors on Thursday, October 17th. They now have an “underperform” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of St. Jude Medical in a research note to investors on Thursday, October 17th. They now have a $59.00 price target on the stock. Finally, analysts at Credit Suisse raised their price target on shares of St. Jude Medical from $55.00 to $60.00 in a research note to investors on Thursday, October 17th. They now have an “outperform” rating on the stock. Three analysts have rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $49.80.
Shares of St. Jude Medical (NYSE:STJ) traded up 1.38% during mid-day trading on Friday, hitting $57.27. 1,914,204 shares of the company’s stock traded hands. St. Jude Medical has a 52-week low of $30.25 and a 52-week high of $54.06. The stock’s 50-day moving average is $52.21 and its 200-day moving average is $46.01. The company has a market cap of $16.723 billion and a price-to-earnings ratio of 23.07.
St. Jude Medical (NYSE:STJ) last released its earnings data on Wednesday, October 16th. The company reported $0.90 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.89 by $0.01. The company had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.32 billion. During the same quarter last year, the company posted $0.83 earnings per share. St. Jude Medical’s revenue was up .9% compared to the same quarter last year.
St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.